CN106421729A - Solution for treating dyshidrosis - Google Patents
Solution for treating dyshidrosis Download PDFInfo
- Publication number
- CN106421729A CN106421729A CN201611113084.5A CN201611113084A CN106421729A CN 106421729 A CN106421729 A CN 106421729A CN 201611113084 A CN201611113084 A CN 201611113084A CN 106421729 A CN106421729 A CN 106421729A
- Authority
- CN
- China
- Prior art keywords
- solution
- pompholyx
- treatment
- retinervus luffae
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 208000005373 Dyshidrotic Eczema Diseases 0.000 title claims abstract description 42
- 201000011414 pompholyx Diseases 0.000 title claims abstract description 42
- 208000013046 dyshidrosis Diseases 0.000 title abstract 4
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims abstract description 23
- 239000000706 filtrate Substances 0.000 claims description 22
- 238000001914 filtration Methods 0.000 claims description 20
- 239000000843 powder Substances 0.000 claims description 15
- 238000000034 method Methods 0.000 claims description 12
- 239000011521 glass Substances 0.000 claims description 10
- 230000008878 coupling Effects 0.000 claims description 9
- 238000010168 coupling process Methods 0.000 claims description 9
- 238000005859 coupling reaction Methods 0.000 claims description 9
- 230000000249 desinfective effect Effects 0.000 claims description 9
- 235000007164 Oryza sativa Nutrition 0.000 claims description 3
- 235000009566 rice Nutrition 0.000 claims description 3
- 235000021419 vinegar Nutrition 0.000 claims description 3
- 241000219112 Cucumis Species 0.000 claims 2
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 claims 2
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 claims 2
- 241000628997 Flos Species 0.000 claims 1
- 240000007594 Oryza sativa Species 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 19
- 239000002994 raw material Substances 0.000 abstract description 4
- 238000002360 preparation method Methods 0.000 abstract description 3
- 241001313857 Bletilla striata Species 0.000 abstract 1
- 244000280244 Luffa acutangula Species 0.000 abstract 1
- 235000009814 Luffa aegyptiaca Nutrition 0.000 abstract 1
- 240000002924 Platycladus orientalis Species 0.000 abstract 1
- 244000273928 Zingiber officinale Species 0.000 abstract 1
- 235000006886 Zingiber officinale Nutrition 0.000 abstract 1
- 235000008397 ginger Nutrition 0.000 abstract 1
- 230000008506 pathogenesis Effects 0.000 abstract 1
- 239000007788 liquid Substances 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 238000010025 steaming Methods 0.000 description 3
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical class C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 2
- 241000209094 Oryza Species 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 208000003322 Coinfection Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 206010017533 Fungal infection Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- 206010037888 Rash pustular Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 208000029561 pustule Diseases 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/13—Coniferophyta (gymnosperms)
- A61K36/14—Cupressaceae (Cypress family), e.g. juniper or cypress
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a solution for treating dyshidrosis. The solution takes Chinese arborvitae twig and leaf, bletilla striata, loofah sponge and ginger juice as raw materials according to the pathogenesis of the dyshidrosis; the prepared solution has a remarkable effect on treating the dyshidrosis; the solution is simple in preparation process and is a preparation without a side effect, and has a relatively high commercial value.
Description
Technical field
The present invention relates to a kind of Chinese Medicines, specifically a kind of solution treating pompholyx.
Background technology
Also known as dysidria rash, pompholyx is department of dermatologry eczema commonly encountered diseases to pompholyx, symmetric betide finger lateral margin,
Or the side of foot.It is the vesicle dermatoses occurring in the palm sole of the foot, for most gatherings or be dispersed in positioned at epidermis depths phlycten, flow after breaking
Go out viscous liquid, after a few days, vesicle absorbs, remain ring-type squama after drying up, have during secondary infection and can form pustule.Modern artificial
Make pressure big, spirit is in high-strung state, the factor such as fungal infection and allergy can result in sending out of pompholyx
Raw.Chang Lianxu shows effect the several years, is difficult to effect a radical cure, a lot of patients are to finally really can not only selecting antibiotic therapy, this danger
Evil is very big.The application is exactly directed to this disease, proposes a kind of solution treating pompholyx, using common several raw materials,
Can conveniently make by oneself it is also possible to be produced in batches, preparation is simple, effect is significant.It takes Cacumen Platycladi and the Pseudobulbus Bletillae (Rhizoma Bletillae) to be closed
Reason collocation, and effect of collaborative Retinervus Luffae Fructuss, add Sucus Zingberis, prepare a kind of the molten of new treatment pompholyx prepared by simple process
Liquid.
Technology contents
The present invention relates to a kind of solution treating pompholyx, it takes Cacumen Platycladi and the Pseudobulbus Bletillae (Rhizoma Bletillae) to close according to the pathogeny of pompholyx
The reason collocation Pseudobulbus Bletillae (Rhizoma Bletillae) has astriction, can absorb the viscous liquid in vesicle, simultaneously by itself and the combination of Cacumen Platycladi leaf composition, mutually
The collaborative treatment promoting affected part, the application has selected Retinervus Luffae Fructuss simultaneously, and its collaborative Cacumen Platycladi etc. prepares this herpes, effect is significant,
It plays can also be so that play the slow releasing function of medicinal liquid, Rhizoma Zingiberis Recens juice when wiping affected part while the drug effect providing itself
There is the effect of sterilization detumescence antibacterial, above-mentioned raw materials are utilized immersion, the composition of Retinervus Luffae Fructuss and Rhizoma Zingiberis Recens juice and side in Rhizoma Zingiberis Recens juice
Excite in the filtrate of Cacumen Platycladi (Cacumen Biotae) and the Pseudobulbus Bletillae (Rhizoma Bletillae), when using, enhance and be used alone one in Cacumen Platycladi, Rhizoma Zingiberis Recens juice, Retinervus Luffae Fructuss or the Pseudobulbus Bletillae (Rhizoma Bletillae)
Plant the effect of composition.
Present disclosure is specifically：
A kind of solution treating pompholyx it is characterised in that：
（1）Choose a certain amount of Cacumen Platycladi and the Pseudobulbus Bletillae (Rhizoma Bletillae) decocts, be filtrated to get filtrate, filtering residue is pulverized, obtain filtering residue powder；
（2）Choose one section of complete Retinervus Luffae Fructus, by step（1）Middle filtering residue powder is uniformly sprinkled upon on Retinervus Luffae Fructuss, is rubbed, by filtering residue
Powder is uniformly rubbed with the hands in the network structure of Retinervus Luffae Fructuss, rubs into Retinervus Luffae Fructuss group and puts in wide mouth glass container；
（3）By step（1）The filtrate obtaining pours step into（2）Glass container in, make filtrate be totally submerged Retinervus Luffae Fructuss group, soak
2-10 hour, a certain amount of Rhizoma Zingiberis Recens juice of Deca, continues to soak 2 hours, that is, the solution of the pompholyx that obtains medical treatment.
The mass ratio of described Cacumen Platycladi and the Pseudobulbus Bletillae (Rhizoma Bletillae) is 2-3：0.5-0.8.
The consumption of described Rhizoma Zingiberis Recens juice is the 1 of filtrate：5-8.
The using method of the solution of described treatment pompholyx choose be directly applied to affected part can by medical silk tops or other
Medical apparatus.
The using method of the described solution for the treatment of pompholyx is the shears crossing medical disinfecting, cuts from Retinervus Luffae Fructuss group
One little group of coupling affected part size, is placed on hospital gauze, then applies in affected part.
The using method of the described solution for the treatment of pompholyx, the shears that medical disinfecting is crossed, cut from Retinervus Luffae Fructuss group
One little group of coupling affected part size, is placed on hospital gauze, several fresh Folium Allii tuberosi juice of Deca, then applies in affected part.
The using method of the described solution for the treatment of pompholyx, the shears that medical disinfecting is crossed, cut from Retinervus Luffae Fructuss group
One little group of coupling affected part size, is placed on hospital gauze, several rice vinegars of Deca, then applies in affected part.
Have the beneficial effect that：
The present invention, according to the pathogeny of pompholyx, takes Cacumen Platycladi and the reasonably combined Pseudobulbus Bletillae (Rhizoma Bletillae) of the Pseudobulbus Bletillae (Rhizoma Bletillae) to have astriction, can
Viscous liquid in absorption vesicle, simultaneously by itself and the combination of Cacumen Platycladi leaf composition, the mutually collaborative treatment promoting affected part, the application is same
Shi Xuanyong Retinervus Luffae Fructuss, its collaborative Cacumen Platycladi etc. prepares this herpes, and effect is significant, while it plays the drug effect providing itself
Can also make to play the slow releasing function of medicinal liquid when wiping affected part, Rhizoma Zingiberis Recens juice has the effect of sterilization detumescence antibacterial, will be upper
State raw material and utilize in Rhizoma Zingiberis Recens juice and soak, excite in the filtrate of the composition of Retinervus Luffae Fructuss and Rhizoma Zingiberis Recens juice and Cacumen Platycladi and the Pseudobulbus Bletillae (Rhizoma Bletillae), make
Used time, enhance and be used alone a kind of effect of composition in Cacumen Platycladi, Rhizoma Zingiberis Recens juice, Retinervus Luffae Fructuss or the Pseudobulbus Bletillae (Rhizoma Bletillae).Cleverly utilize Fructus Luffae
The effect of network.
Specific embodiment
Embodiment 1：
A kind of solution treating pompholyx it is characterised in that：
（1）Choose a certain amount of Cacumen Platycladi and the Pseudobulbus Bletillae (Rhizoma Bletillae) decocts, be filtrated to get filtrate, filtering residue is pulverized, obtain filtering residue powder；Described Cacumen Platycladi
The mass ratio of leaf and the Pseudobulbus Bletillae (Rhizoma Bletillae) is 2：0.6.
（2）Choose one section of complete Retinervus Luffae Fructus, by step（1）Middle filtering residue powder is uniformly sprinkled upon on Retinervus Luffae Fructuss, is rubbed, will
Filtering residue powder is uniformly rubbed with the hands in the network structure of Retinervus Luffae Fructuss, rubs into Retinervus Luffae Fructuss group and puts in wide mouth glass container；
（3）By step（1）The filtrate obtaining pours step into（2）Glass container in, make filtrate be totally submerged Retinervus Luffae Fructuss group, soak
2-10 hour, a certain amount of Rhizoma Zingiberis Recens juice of Deca, continues to soak 2 hours, that is, the solution of the pompholyx that obtains medical treatment.Described Rhizoma Zingiberis Recens juice
Consumption is the 1 of filtrate：6.
The using method of the described solution for the treatment of pompholyx is the shears crossing medical disinfecting, cuts from Retinervus Luffae Fructuss group
One little group of coupling affected part size, is placed on hospital gauze, then applies in affected part.
Embodiment 2：
A kind of solution treating pompholyx it is characterised in that：
（1）Choose a certain amount of Cacumen Platycladi and the Pseudobulbus Bletillae (Rhizoma Bletillae) decocts, be filtrated to get filtrate, filtering residue is pulverized, obtain filtering residue powder；Described Cacumen Platycladi
The mass ratio of leaf and the Pseudobulbus Bletillae (Rhizoma Bletillae) is 3：0.8.
（2）Choose one section of complete Retinervus Luffae Fructus, by step（1）Middle filtering residue powder is uniformly sprinkled upon on Retinervus Luffae Fructuss, is rubbed, will
Filtering residue powder is uniformly rubbed with the hands in the network structure of Retinervus Luffae Fructuss, rubs into Retinervus Luffae Fructuss group and puts in wide mouth glass container；
（3）By step（1）The filtrate obtaining pours step into（2）Glass container in, make filtrate be totally submerged Retinervus Luffae Fructuss group, soak
2-10 hour, a certain amount of Rhizoma Zingiberis Recens juice of Deca, continues to soak 2 hours, that is, the solution of the pompholyx that obtains medical treatment.Described Rhizoma Zingiberis Recens juice
Consumption is the 1 of filtrate：8.
The using method of the described solution for the treatment of pompholyx, the shears that medical disinfecting is crossed, cut from Retinervus Luffae Fructuss group
One little group of coupling affected part size, is placed on hospital gauze, several fresh Folium Allii tuberosi juice of Deca, then applies in affected part.
Embodiment 3：
A kind of solution treating pompholyx it is characterised in that：
（1）Choose a certain amount of Cacumen Platycladi and the Pseudobulbus Bletillae (Rhizoma Bletillae) decocts, be filtrated to get filtrate, filtering residue is pulverized, obtain filtering residue powder；Described Cacumen Platycladi
The mass ratio of leaf and the Pseudobulbus Bletillae (Rhizoma Bletillae) is 2：0.8.
（2）Choose one section of complete Retinervus Luffae Fructus, by step（1）Middle filtering residue powder is uniformly sprinkled upon on Retinervus Luffae Fructuss, is rubbed, will
Filtering residue powder is uniformly rubbed with the hands in the network structure of Retinervus Luffae Fructuss, rubs into Retinervus Luffae Fructuss group and puts in wide mouth glass container；
（3）By step（1）The filtrate obtaining pours step into（2）Glass container in, make filtrate be totally submerged Retinervus Luffae Fructuss group, soak
2-10 hour, a certain amount of Rhizoma Zingiberis Recens juice of Deca, continues to soak 2 hours, that is, the solution of the pompholyx that obtains medical treatment.Described Rhizoma Zingiberis Recens juice
Consumption is the 1 of filtrate：8.
The using method of the described solution for the treatment of pompholyx, the shears that medical disinfecting is crossed, cut from Retinervus Luffae Fructuss group
One little group of coupling affected part size, is placed on hospital gauze, several rice vinegars of Deca, then applies in affected part.
Contrast test 1：Steaming and decocting Cacumen Platycladi obtains Solution In The Treatment pompholyx, has certain effect, but effect is not notable.
Contrast test 2：Steaming and decocting Retinervus Luffae Fructuss obtain Solution In The Treatment pompholyx, and therapeutic effect is poor, not as good as Cacumen Platycladi.
Contrast test 3：Using Rhizoma Zingiberis Recenss juice for treating pompholyx, there is certain effect, but effect is not notable, inferior to Cacumen Platycladi
Leaf.
Contrast test 4：The steaming and decocting Pseudobulbus Bletillae (Rhizoma Bletillae) obtains Solution In The Treatment pompholyx, does not substantially have effect.
Affected part is applied in affected part with above-mentioned solution respectively, twice a day, and one time 30 minutes.
Result of the test：The cure rate of the Solution In The Treatment pompholyx of embodiment 1-3 is more than 95%, and the effect of contrast test 1
Only percent 50%, all in 10-15%, the cure rate of contrast test 4 is 1-2% to the cure rate of contrast test 2-3.
Claims (7)
1. a kind of solution treating pompholyx it is characterised in that：
（1）Choose a certain amount of Cacumen Platycladi and the Pseudobulbus Bletillae (Rhizoma Bletillae) decocts, be filtrated to get filtrate, filtering residue is pulverized, obtain filtering residue powder；
（2）Choose one section of complete Retinervus Luffae Fructus, by step（1）Middle filtering residue powder is uniformly sprinkled upon on Retinervus Luffae Fructuss, is rubbed, by filtering residue
Powder is uniformly rubbed with the hands in the network structure of Retinervus Luffae Fructuss, rubs into Retinervus Luffae Fructuss group and puts in wide mouth glass container；
（3）By step（1）The filtrate obtaining pours step into（2）Glass container in, make filtrate be totally submerged Retinervus Luffae Fructuss group, soak
2-10 hour, a certain amount of Rhizoma Zingiberis Recens juice of Deca, continues to soak 2 hours, that is, the solution of the pompholyx that obtains medical treatment.
2. according to claim 1 treatment pompholyx solution it is characterised in that：Described Cacumen Platycladi and the mass ratio of the Pseudobulbus Bletillae (Rhizoma Bletillae)
For 2-3：0.5-0.8.
3. according to claim 1 treatment pompholyx solution it is characterised in that：The consumption of described Rhizoma Zingiberis Recens juice is filtrate
1：5-8.
4. the using method of the solution for the treatment of pompholyx as claimed in claim 1 is chosen and is directly applied to affected part, by medical silk floss
Ball or other medical apparatus.
5. a kind of using method of the solution for the treatment of pompholyx as claimed in claim 1 is it is characterised in that by medical disinfecting mistake
Shears, a little group of coupling affected part size is cut from Retinervus Luffae Fructuss group, is placed on hospital gauze, then applies in affected part.
6. a kind of using method of the solution for the treatment of pompholyx as claimed in claim 1, the shears that medical disinfecting is crossed, from silk
One little group of coupling affected part size is cut on melon network group, is placed on hospital gauze, several fresh Folium Allii tuberosi juice of Deca, then applies
Affected part.
7. a kind of using method of the solution for the treatment of pompholyx as claimed in claim 1, the shears that medical disinfecting is crossed, from silk
One little group of coupling affected part size is cut on melon network group, is placed on hospital gauze, several rice vinegars of Deca, then apply and suffering from
Place.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201611113084.5A CN106421729A (en) | 2016-12-07 | 2016-12-07 | Solution for treating dyshidrosis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201611113084.5A CN106421729A (en) | 2016-12-07 | 2016-12-07 | Solution for treating dyshidrosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106421729A true CN106421729A (en) | 2017-02-22 |
Family
ID=58216111
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201611113084.5A Withdrawn CN106421729A (en) | 2016-12-07 | 2016-12-07 | Solution for treating dyshidrosis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106421729A (en) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103083601A (en) * | 2013-03-01 | 2013-05-08 | 李玉娟 | Traditional Chinese medical composition for treating pompholyx |
-
2016
- 2016-12-07 CN CN201611113084.5A patent/CN106421729A/en not_active Withdrawn
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103083601A (en) * | 2013-03-01 | 2013-05-08 | 李玉娟 | Traditional Chinese medical composition for treating pompholyx |
Non-Patent Citations (3)
| Title |
|---|
| 朱学骏等: "《现代皮肤病性病诊疗手册（第二版）》", 28 February 2001, 北京医科大学出版社 * |
| 胡小勤: "《中药学》", 31 January 2014, 西安交通大学出版社 * |
| 韦桂宁等: "《小偏方胜名医 独特偏方祛百病》", 30 September 2015, 军事医学科学出版社 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN113952380A (en) | Traditional Chinese medicine composition for treating rhinitis, traditional Chinese medicine preparation, and preparation method and application thereof | |
| CN104415229A (en) | Traditional Chinese medicine water decoction for treating tinnitus | |
| CN106421729A (en) | Solution for treating dyshidrosis | |
| CN101590132B (en) | Whelk-removing liniment and preparation method thereof | |
| CN103655301A (en) | Tooth paste containing artemisia rupestris extract and preparation method thereof | |
| CN101069739A (en) | Natural-plant-essence anti-inhibiting-bacteria preparation and preparing method | |
| CN102824511B (en) | Miao medicine used for oralcavity and preparation technology | |
| CN102462819A (en) | Chinese medicinal composition for treating otitis media | |
| CN104606397A (en) | Medicine for oral administration for treating haemorrhage after eye injury and preparation method thereof | |
| CN101569677A (en) | Chinese patent medicament for treating conjunctival congestion and preparation method thereof | |
| CN1065764C (en) | Quickly-acting antalgesic liniment and its preparing process | |
| CN104306764B (en) | A kind of Chinese medicine compound prescription spray for being used to control rhinitis | |
| CN1689622A (en) | Liquor for treating beriberi | |
| CN101559136B (en) | Combined medicament for treating tinea corporis and tinea manus and pedis and preparation method thereof | |
| CN104189274A (en) | Cold injury treatment liquid and production method thereof | |
| CN105521326A (en) | Traditional Chinese medicine for treating hebra prurigo | |
| CN105168453A (en) | Decoction medicine capable of treating functional uterine bleeding and preparation method of decoction medicine | |
| CN105168432A (en) | Pharmaceutical composition for promoting fracture repair | |
| CN104771626A (en) | Oral medicine for treating vicarious menstruation and preparation method thereof | |
| CN110870911A (en) | Chinese herbal medicine external plaster for osmotic therapy and preparation method and application thereof | |
| CN104257777A (en) | Traditional Chinese medicine composition for treating rhinitis, nasosinusitis and frontal sinusitis and preparation method of traditional Chinese medicine composition | |
| CN104491403A (en) | Medicine for treating central retinochoroiditis and preparation method | |
| CN116983362A (en) | Preparation method of medicine for treating hemorrhoids | |
| CN102145074A (en) | Medicated wine with function of smoking cessation | |
| CN112023004A (en) | Traditional Chinese medicine bi tong paste |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WW01 | Invention patent application withdrawn after publication | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20170222 |